LEADER 01305nam  2200385   450 
001 9910693896103321
005 20221106100400.0
035   $a(CKB)3450000000002439
035   $a(NjHacI)993450000000002439
035   $a(EXLCZ)993450000000002439
100   $a20221106d2002      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aCardiovascular effects of epinephrine on hypertensive dental patients /$fJames D. Bader, Arthur J. Bonito, and Daniel A. Shugars
210  1$aRockville (MD) :$cAgency for Healthcare Research and Quality (US),$d[2002]
210  4$dİ2002
215   $a1 online resource (67 pages)
225 1 $aEvidence Reports/Technology Assessments ;$vNumber 48
320   $aIncludes bibliographical references.
410  0$aEvidence report/technology assessment ;$vNumber 48.
606   $aAdrenaline
615  0$aAdrenaline.
676   $a016.61536
700   $aBader$b James D.$01351912
702   $aBonito$b Arthur J.
702   $aShugars$b Daniel A.
801  0$bNjHacI
801  1$bNjHacI
906   $aBOOK
912   $a9910693896103321
996   $aCardiovascular effects of epinephrine on hypertensive dental patients$93140379
997   $aUNINA